Health care
-
PublishedOctober 2, 2016
Zika babies may have delayed defects
Health experts say problems can affect even babies not born with abnormally small heads.
-
PublishedSeptember 30, 2016
Good Night Lights bring ‘minute of magic’ in Providence
A nightly display of lights by strangers is a highly anticipated ritual for a Rhode Island children's hospital.
-
PublishedSeptember 30, 2016
Small Westbrook lab in race to help speed up testing for Zika
ViroStat hopes its antibodies will be chosen by diagnostic companies and lead to results in minutes rather than weeks, and benefit people in Third World countries.
-
PublishedSeptember 29, 2016
Caffeine may help to prevent dementia, study suggests
The study finds higher caffeine intake in women age 65 and older is associated with reduced odds of dementia.
-
PublishedSeptember 25, 2016
Donating baby’s body for research leads Washington mother to write book
Such donations get less attention but can lead to cures, Sarah Gray explains in 'A Life Everlasting, The Extraordinary Story of One Boy's Gift to Medical Science.'
-
PublishedSeptember 25, 2016
Seven overdose deaths in 1 day reported in Cleveland area
The outbreak comes after 52 people died from heroin or fentanyl during August.
-
PublishedSeptember 23, 2016
FDA approves lower-cost alternative to drug Humira
It's the fourth time that the FDA has formally approved a so-called biosimilar, the industry term for a lower-cost version of a biotech drug.
-
PublishedSeptember 23, 2016
Maine’s flu season is off to its earliest start in at least 10 years
The disease typically doesn't appear in the state until October or later, but the Maine CDC is already reporting four cases.
-
PublishedSeptember 23, 2016
Maine attorney general signs onto lawsuit against maker of addiction treatment drug Suboxone
The attorneys general of 36 states, including Maine, accuse Indivior of conspiring with MonoSol Rx to keep cheaper, generic versions of the drug off the market.
-
PublishedSeptember 21, 2016
CEO defends price of EpiPen to angry lawmakers
One congressman points out that executives for the company, Mylan, earned $300 million over five years while the cost for the popular allergy medicine soared.
- ← Previous Page
- 1
- …
- 253
- 254
- 255
- 256
- 257
- …
- 352
- Next Page →